A new stressed test to predict the foreign matter formation of minodronic acid in solution

International Journal of Pharmaceutics

Volumn 251, Issue 1-2, 2003, Pages 99-106

  Nakamura, Katsutoshi ^a   Yokohama, Shigeharu ^a   Katsuma, Masataka ^a   Sawada, Toyohiro ^a   Sonobe, Takashi ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Aluminum ion; Complex; Minodronic acid; New stressed test; Parenteral formulation; Particle

Indexed keywords

ACID; ALUMINUM; CITRIC ACID; DIETHANOLAMINE; GLYCEROL; MANNITOL; MEGLUMINE; MINODRONIC ACID; UNCLASSIFIED DRUG;

ACCELERATION; AMPOULE; ARTICLE; DRUG FORMULATION; DRUG STABILITY; EVALUATION; FREEZING; HIGH TEMPERATURE; LEACHING; LOW TEMPERATURE; PARTICULATE MATTER; PREDICTION; PRIORITY JOURNAL; THAWING;

DIPHOSPHONATES; DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; FORECASTING; IMIDAZOLES; PHARMACEUTICAL SOLUTIONS; STRESS, MECHANICAL; TECHNOLOGY, PHARMACEUTICAL;

EID: 0037472337     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00594-X     Document Type: Article

References (16)

1. Borchert S.J., Abe A., Aldrich D.S., Fox L.E., Freeman J.E., White R.D. Particulate matter in parenteral products: a review. J. Parenter. Sci. Technol. 40:1986;212-241.
2. Claessens R.A.M.J., van der Linden J.G.M. Stability constants of tin(II) and calcium diphosphonate complexes. J. Inorg. Biochem. 21:1984;73-82.
3. Gallelli J.F., Groves M.J. USP perspective on particle contamination of injectable products. J. Parenter. Sci. Technol. 47:1993;289-292.
4. Hasegawa K., Hashi K., Okada R. Physicochemical stability of pharmaceutical phosphate buffer solutions. I. Complexation behavior of Ca(II) with additives in phosphate buffer solutions. J. Parenter. Sci. Technol. 36:1982;128-133.
5. Hasegawa K., Hashi K., Okada R. Physicochemical stability of pharmaceutical phosphate buffer solutions II. Complexation behavior of Al(III) with additives in phosphate buffer solutions. J. Parenter. Sci. Technol. 36:1982;168-173.
6. Hasegawa K., Hashi K., Okada R. Physicochemical stability of pharmaceutical phosphate buffer solutions III. Gel filtration chromatography of Al(III) complex formed in phosphate buffer solutions. J. Parenter. Sci. Technol. 36:1982;174-178.
7. Hasegawa K., Hashi K., Okada R. Physicochemical stability of pharmaceutical phosphate buffer solutions IV. Prevention of precipitation in parenteral phosphate solutions. J. Parenter. Sci. Technol. 36:1982;210-215.
8. Hasegawa K., Hashi K., Okada R. Physicochemical stability of pharmaceutical phosphate buffer solutions V. Precipitation behavior in phosphate buffer solutions. J. Parenter. Sci. Technol. 37:1982;38-45.
9. Hoiberg C.P. Aluminum in parenteral products: overview of chemistry concerns and regulatory actions. J. Parenter. Sci. Technol. 43:1989;127-131.
10. Kibbe A.H. Handbook of Pharmaceutical Excipients. third ed. 2000;327, 517 American Pharmaceutical Association; Pharmaceutical Press, Washington, DC; London, UK.
11. Kudo M., Abe T., Motoie H., Nagao Y., Kawamuki K., Ouchi N., Kawashima H. Pharmacological profile of new bisphosphonate, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bis(phosphonic acid). Bone Miner. 17:1992;170.
12. Kudo M., Abe T., Kawamuki K., Yamaoka E., Isomura Y., Takeuchi M., Kawashima H. Effect of YM175 on experimental hypercalcemia and tumor-induced osteolysis in rats. J. Bone Miner. Res. 5:1990;S166.
13. Lamson M.L., Fox J.L., Higuchi W.I. Calcium and 1-hydroxyethylidene-1,1-bisphosphonic acid: polynuclear complex formation in the physiological range of pH. Int. J. Pharm. 21:1984;143-154.
14. Nakamura K., Tanaka T., Saito K., Yokohama S., Sonobe T. Stabilization of minodronic acid in aqueous solution for parenteral formulation. Int. J. Pharm. 222:2001;91-99.
15. Nakamura K., Yokohama S., Sonobe T. Failure of stability prediction for minodronic acid injectable by accelerated stability testing. Int. J. Pharm. 241:2002;65-71.
16. Pavanetto F., Genta I., Conti B., Modena T., Montanari L. Aluminum, cadmium and lead in large volume parenterals: contamination levels and sources. Int. J. Pharm. 54:1989;143-148.